You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

CHLOROQUINE PHOSPHATE - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard


What are the generic sources for chloroquine phosphate and what is the scope of freedom to operate?

Chloroquine phosphate is the generic ingredient in three branded drugs marketed by Sanofi Aventis Us, Hikma Pharms, Impax Labs, Ipca Labs Ltd, Md Pharm, Natco Pharma Ltd, Purepac Pharm, Suven Pharms, Teva, and Watson Labs, and is included in fifteen NDAs. Additional information is available in the individual branded drug profile pages.

There are two drug master file entries for chloroquine phosphate. Seven suppliers are listed for this compound.

Summary for CHLOROQUINE PHOSPHATE
US Patents:0
Tradenames:3
Applicants:10
NDAs:15
Drug Master File Entries: 2
Finished Product Suppliers / Packagers: 7
Raw Ingredient (Bulk) Api Vendors: 109
Clinical Trials: 49
Patent Applications: 1,986
What excipients (inactive ingredients) are in CHLOROQUINE PHOSPHATE?CHLOROQUINE PHOSPHATE excipients list
DailyMed Link:CHLOROQUINE PHOSPHATE at DailyMed
Recent Clinical Trials for CHLOROQUINE PHOSPHATE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
University of ArizonaPhase 1
Translational Genomics Research InstitutePhase 1
HonorHealth Research InstitutePhase 1

See all CHLOROQUINE PHOSPHATE clinical trials

Pharmacology for CHLOROQUINE PHOSPHATE
Drug ClassAntimalarial
Anatomical Therapeutic Chemical (ATC) Classes for CHLOROQUINE PHOSPHATE

US Patents and Regulatory Information for CHLOROQUINE PHOSPHATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Purepac Pharm CHLOROQUINE PHOSPHATE chloroquine phosphate TABLET;ORAL 080886-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Impax Labs CHLOROQUINE PHOSPHATE chloroquine phosphate TABLET;ORAL 080880-001 Approved Prior to Jan 1, 1982 AA RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Sanofi Aventis Us ARALEN PHOSPHATE W/ PRIMAQUINE PHOSPHATE chloroquine phosphate; primaquine phosphate TABLET;ORAL 014860-002 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Teva CHLOROQUINE PHOSPHATE chloroquine phosphate TABLET;ORAL 087504-001 Jan 13, 1982 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Natco Pharma Ltd CHLOROQUINE PHOSPHATE chloroquine phosphate TABLET;ORAL 091621-001 Jan 21, 2011 AA RX No Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Watson Labs CHLOROQUINE PHOSPHATE chloroquine phosphate TABLET;ORAL 088030-001 Dec 21, 1982 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.